Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2006 1
2007 1
2008 1
2009 2
2010 2
2011 3
2012 4
2013 2
2014 1
2016 3
2017 3
2018 7
2019 6
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapeutic Challenges for Pediatric Cancers.
Hutzen B, Ghonime M, Lee J, Mardis ER, Wang R, Lee DA, Cairo MS, Roberts RD, Cripe TP, Cassady KA. Hutzen B, et al. Among authors: cassady ka. Mol Ther Oncolytics. 2019 Aug 28;15:38-48. doi: 10.1016/j.omto.2019.08.005. eCollection 2019 Dec 20. Mol Ther Oncolytics. 2019. PMID: 31650024 Free PMC article. Review.
The Antiviral Apparatus: STING and Oncolytic Virus Restriction.
Lee J, Ghonime MG, Wang R, Cassady KA. Lee J, et al. Among authors: cassady ka. Mol Ther Oncolytics. 2019 Mar 20;13:7-13. doi: 10.1016/j.omto.2019.02.002. eCollection 2019 Jun 28. Mol Ther Oncolytics. 2019. PMID: 30989105 Free PMC article. Review.
Oncolytic Virotherapy for the Treatment of Malignant Glioma.
Foreman PM, Friedman GK, Cassady KA, Markert JM. Foreman PM, et al. Among authors: cassady ka. Neurotherapeutics. 2017 Apr;14(2):333-344. doi: 10.1007/s13311-017-0516-0. Neurotherapeutics. 2017. PMID: 28265902 Free PMC article. Review.
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution.
Hedberg J, Studebaker A, Smith L, Chen CY, Westfall JJ, Cam M, Gross A, Hernandez-Aguirre I, Martin A, Kim D, Dhital R, Kim Y, Roberts RD, Cripe TP, Mardis ER, Cassady KA, Leonard J, Miller KE. Hedberg J, et al. Among authors: cassady ka. Mol Ther Oncolytics. 2023 Jul 19;30:39-55. doi: 10.1016/j.omto.2023.07.006. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37583388 Free PMC article.
Please stand by: how oncolytic viruses impact bystander cells.
Sprague L, Braidwood L, Conner J, Cassady KA, Benencia F, Cripe TP. Sprague L, et al. Among authors: cassady ka. Future Virol. 2018 Sep;13(9):671-680. doi: 10.2217/fvl-2018-0068. Epub 2018 Aug 8. Future Virol. 2018. PMID: 30416535 Free PMC article. Review.
Targeting pediatric cancer stem cells with oncolytic virotherapy.
Friedman GK, Cassady KA, Beierle EA, Markert JM, Gillespie GY. Friedman GK, et al. Among authors: cassady ka. Pediatr Res. 2012 Apr;71(4 Pt 2):500-10. doi: 10.1038/pr.2011.58. Epub 2012 Feb 15. Pediatr Res. 2012. PMID: 22430386 Free PMC article. Review.
Ulceroglandular tularemia in a nonendemic area.
Guffey MB, Dalzell A, Kelly DR, Cassady KA. Guffey MB, et al. Among authors: cassady ka. South Med J. 2007 Mar;100(3):304-8. doi: 10.1097/01.smj.0000242333.60112.7f. South Med J. 2007. PMID: 17396737 Review.
41 results